biote Corp.
BTMD | NASDAQ
$1.17
+$0.06 (+5.41%)
Nov 2, 2026, 12:46 PM ET · Market open
Company Profile
Biote Corp. is dedicated to supporting and developing medical practices that focus on hormone optimization. The company provides a comprehensive system for its Biote-certified healthcare professionals, enabling them to correct imbalances in patients' hormone, vitamin, and mineral levels. This includes authorizing the prescription of bioidentical hormone treatments and suggesting suitable dietary supplements. Furthermore, Biote offers its own line of branded nutritional supplements and supplies sterile kits for inserting hormone pellets for both male and female individuals. Founded in 2011, Biote Corp. is based in Irvine, Texas.
Key Executives
| Name | Position |
|---|---|
| Robert Peterson | Interim CEO, CFO & Chief Business Officer |
| Joel Pickering | Chief Marketing Officer |
| John J. Olsen | Chief Information Officer |
| Cory Rice | Chief Clinical Advisor & Member of Medical Advisory Board |
| Dan Monico | General Counsel |
| Jade Beutler | Head of Nutraceuticals |
| Joey Lopes | SVP of Strategy & Commercial Operations |
| Komal Bajaj | Chief Medical Officer |
| Marc D. Beer | Executive Chairman |
| Richard Kevin Key | Chief Digital Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 18, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Sep 01, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 28, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Aug 12, 2026 | 4 | Filing |
| Aug 07, 2026 | 10-Q | Quarterly Report |
| Aug 05, 2026 | 8-K | Current Report |
| Jul 27, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Jun 17, 2026 | 8-K/A | [Amend] Current Report |
| Jun 16, 2026 | 4 | Filing |
| Jun 10, 2026 | 4 | Filing |
biote Corp.
| Country | United States |
| IPO Date | Apr 28, 2021 |
| Industry | Medical - Care Facilities |
| Sector | Healthcare |
| Employees | 223 |
| CEO | Robert C. Peterson |
Contact Details
1875 West Walnut Hill Lane Irving,
Texas 75038 United States
Stock Details
| Ticker Symbol | BTMD |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001819253 |
| CUSIP Number | 090683103 |
| ISIN Number | US0906831039 |
| SIC Code | 2833 |
Add to Watchlist
Select watchlists to add or remove BTMD